It is known that a large number of tumor-infiltrating lymphocytes (TILs) results in a better prognosis for cancer patients24, and that patients with a high number of effector cells in tumors were more likely to respond favorably to anti-CTLA4 Ab25. The gene discussed is CTLA4; the disease is cancer.